[Clinico-epidemiological study of kala-azar in the south of Madrid].
F J
FJ
de la Serna
E
E
Salto
D
D
Valdés
R
R
Vos Saus
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D008536:Meglumine / Q000009:adverse effects / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D013012:Sorbitol / Q000031:analogs & derivatives*; D013030:Spain
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D013012:Sorbitol; D008536:Meglumine; D000077485:Meglumine Antimoniate
Estudio clínico-epidemiológico del kala-azar en el sur de Madrid.